The Global Medical Rehabilitation Robotics Industry is poised for an extraordinary surge, with a projected Compound Annual Growth Rate (CAGR) of 15.2%. By 2033, the market is expected to reach a remarkable valuation of US$ 1.76 Billion, a substantial increase from the US$ 366.2 Million recorded in 2022.
The Pediatrics Rehabilitation Robotics Market, a sector still in its nascent stages, is set for a promising future. The expansion of rehabilitation services dedicated to patients with conditions such as autism and cerebral palsy is anticipated to be a key driver of this market’s growth.
In alignment with the World Health Organization (WHO) reports, the year 2021 witnessed a staggering 1.71 Billion people grappling with musculoskeletal disorders. This alarming figure underscores the pressing need for the adoption of rehabilitation robots. These cutting-edge devices play a pivotal role in assisting physically challenged and differently-abled individuals in maintaining balance, standing up, and sustaining their gait.
Medical rehabilitation robotics offers a multitude of benefits, notably affording individuals with spinal cord injuries the opportunity to stand and walk at a reduced metabolic cost. Furthermore, this industry is a hotbed of technological advancements, incorporating Machine Learning (ML) and Artificial Intelligence (AI) alongside advanced sensor technologies. The burgeoning geriatric population is an additional factor fueling the exponential growth of the medical rehabilitation robotics industry.
Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14242
Along the above-mentioned lines, PARO comes across as companion robot that has been specially designed for those suffering from Alzheimer’s, dementia, and various other cognition disorders. Dr. Takanori Shibata from Japan’s National Institute of Advanced Industrial Science and Technology has come up with this assistive robot for helping those with disabilities fulfil daily activities like eating and walking.
Robotic lower-body exoskeleton is being used to assist the ones with paralysis of the lower limbs and does encourage muscle activity therein.
Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Medical Rehabilitation Robotics Market’ with its team of analysts and consultants deploying a 360-degree view in its primary, secondary, and tertiary modes of research.
“With Spike in cases of stroke, the global medical rehabilitation robotics industry is expected to go great guns in the near future”, says an analyst from Future Market Insights.
Key Takeaways from the Medical Rehabilitation Robotics Industry
- North America holds more than 40% of the market share due to growing incidences of spinal cord injury followed by rising aging and disabled population.
- Europe holds a significant market share with Germany leading from the front with Spain, Denmark, and the UK leading from the front.
- The Asia-Pacific is expected to grow at a rapid pace in the medical rehabilitation robotics industry with countries like Japan obtaining the status of ‘super-aging society’.
Exploring the study’s key assumptions. Ask an Analyst Now.
https://www.futuremarketinsights.com/ask-question/rep-gb-14242
Competitive Robotics
- Ekso Bionics Holdings, Inc. received approval from the US FDA for marketing the EksoNR robotic exoskeleton for usage with patients suffering from MS (Multiple Sclerosis).
- Tyromotion, of late, completed acquisition of yband therapy AG (a Swiss-based start-up) for encouraging patients’ ownership of recovery with cutting-edge movement trackers.
- Bionik Laboratories Corporation, in January 2019, did launch InMotion ARM/HAND robotic system to clinically rehabilitate stroke survivors and the ones having mobility impairments owing to neurological conditions. The enhanced robotic system has been developed according to principles of motor learning as well as neuro-plasticity and makes use of AI and data analysis for offering individualized therapy to the patients.
- ReWalk Robotics, Inc., in June 2019, did announce that the US FDA approved the ReStore soft exo-suit system for selling to the rehabilitation centers all over the US.
- Cyberdyne Inc., in January 2018, obtained approval from the US FDA to sell HAL (Hybrid Assistive Limb) lower-body exoskeleton in the licensed medical facilities all over the US.
- Stryker Corporation, in the year 2020, did receive regulatory approval for MAKO robotic surgery system in Japan for partial knee indication.
- Accuray, in 2020, did launch CyberKnife S7 System, which comes across as a next-generation CyberKnife platform with real-time, advanced, AI-driven motion tracking as well as synchronization treatment delivery for SBRT (stereotactic body radiation therapy) and SRS (stereotactic radiosurgery).
- Medtronic, in 2020, completed acquisition of Medicrea through AI, patient specific implants, and predictive modeling.
- Intuitive Surgical, in 2019, did receive clearance from the US FDA regarding da Vinci Single-port Surgical System.
Key Market Players:
- Ekso Bionics Holdings Inc.
- AlterG Inc.
- Bionik Laboratories Corp.
- Cyberdyne Inc.
- Rewalk Robotics.
- Instead Technoligies Ltd.
- Hocoma AG.
- Fourier Intelligene
- Tyromotion Gmbh
- Toyota Motor Corporation
- BeatBots LLC
- Bioxtreme
- Rex Bionics Inc.
- LEADERS REHAB ROBOT Co. Ltd.
Click Here Today To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/14242
Key Segments Covered in Medical Rehabilitation Robotics Industry Research
By Product:
- Exoskeletons
- Therapeutic/ Assistive
By Extremity:
- Upper Extremity
- Arm
- Wrist
- Shoulder
- Elbow
- Lower Extremity
By Therapy:
- Limb Mobility
- Gait
- Sensory
By Patient:
- Adults
- Pediatric
By Application:
- Neurorehabilitation
- Physical Rehabilitation
- Others
By End user:
- Hospitals
- Wellness centers
- Rehabilitation centers
- Homecare
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube